What, according to you, were the various challenges faced by the companies involved in the disease diagnostics space during the pandemic?
As COVID-19 was a novel virus, detecting, containing, treating and managing the disease proved to be difficult for everyone. Lockdowns across the world to contain the disease posed additional logistical burden. Test, Trace and Treat became the diktat to fight COVID-19 and 'Testing' came under the spotlight.
Initially we faced a challenge in procurement and supply of test kits, reagents and other consumables. This was resolved by working closely with our reliable and sturdy network of suppliers. ICMR quickly validating the newly launched test kits also came in as a huge help.
COVID also forced us to think outside the box- literally, when we set-up a BSL2 level Container Lab in our National Reference Lab in Rohini, Delhi. This helped us processing greater volumes of samples simply by providing a place to unbox and add buffer to the samples before the actual testing started. With this, we were able to insulate our lab premises and staff from threat of COVID.
As everyone was dealing with the unknown, teething troubles with various states in terms of compliance, operations, reporting and pricing were also faced.
Which approaches and techniques are considered suitable (and safe) for diagnosis of infectious diseases today?
Infectious diseases are caused by Bacteria, Viruses, Fungi and Parasites and the clinical symptoms are often a mix complex of fever, cough, cold, diarrhea, rashes, etc. which are generally site specific. The best way to diagnose infectious diseases is to go for site-specific sampling and subject it to PCR (Polymerase Chain Reaction) that detects genetic material from a specific organism. This is the fastest, most sensitive and specific way to detect the causative agent of the infection.
Bu hikaye Healthcare Radius dergisinin December 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Healthcare Radius dergisinin December 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Centre For Sight forms JV with Laxmi Eye Hospital
Expands in Maharashtra; to collaborate with Laxmi Eye Hospital for local market reach.
Diverse information sources are reshaping treatment patterns - Study
A CLIRNET study finds that doctors exposed to multichannel content, demonstrate a 50 percent higher likelihood of diversifying their treatment patterns.
Advanced test for IRD diagnosis launched
Nucleome Informatics unveils an advanced genetic test for diagnosing inherited retinal diseases (IRDS
A device for facial muscle toning, anti-aging. Interested?
Dr Rickson's Dermatherapie Clinic launches device for facial muscle toning, lifting, tightening, and texture improvement.
Therapeutics startup Wundrsight raises $400K in seed round
Wundrsight secures $400,000 in seed round led by Inflection Point Ventures. The fresh funds will be utilized in development of company's VR-based mental health solutions
Odisha's Komal Panda wins James Dyson award
Komal Panda wins the James Dyson Award 2024 for her innovation for diabetes patients, Novocarry, a portable cooling carrier that helps in keeping insulin under desired temperatures.
REHABILITATION SERVICES: AN EVOLVING LANDSCAPE
India's healthcare rehabilitation services market is rapidly evolving, driven by rising demand and investments.
FIVE CYBERKNIFE RADIOSURGERY BENEFITS IN HEAD AND NECK CANCER TREATMENT
Explore why cyberknife radiosurgery promises to be a game-changer in head and neck cancer treatment by revolutionizing care and improving patient outcomes.
CARING FOR THE ELDERLY
India's aging population presents a pressing need for comprehensive healthcare services. Learn how the country's healthcare system can address this challenge.
TACKLING INDIA'S IMMUNIZATION CHALLENGE
India's vast geography and large population challenge comprehensive immunization. Despite successes in children's immunization, more work is needed. A report.